8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2016 / Double-blind, randomized, placebo-controlled trial
Twenty sedentary adults aged ~50 were randomized to consume 20 g of dark chocolate or placebo daily for 3 months, with 17 completing the study. In the dark chocolate group (n = 9), VO2 max showed a 17% increase (p = 0.056) and maximum work achieved increased significantly (p = 0.026), alongside higher HDL (p = 0.005) and decreased triglycerides (p = 0.07), with no changes in placebo (n = 8). Skeletal muscle showed significant increases in LKB1, AMPK, and PGC1α proteins and their active forms, citrate synthase activity, and reduced glutathione, as well as decreased protein carbonylation, without changes in mitochondrial density. The authors note larger clinical studies are warranted to confirm these observations.
Taub PR, Ramirez-Sanchez I, Patel M, et al. Food Funct, 2016. PMID 27491778
2016 / Randomized controlled trial
Among 62 patients with peripheral artery disease who had high blood pressure at baseline, dietary flaxseed lowered central systolic and diastolic blood pressures by an average of 10 and 6 mm Hg compared to placebo. Flaxseed did not significantly alter the augmentation index or other cardiac function indices. The reduction in central blood pressure was linked to decreases in specific plasma oxylipins, including 16-hydroxyeicosatetraenoic acid and thromboxane B2.
Caligiuri SP, Rodriguez-Leyva D, Aukema HM, et al. Hypertension, 2016. PMID 27528063
2016 / Randomized crossover trial
In a randomized double-blind crossover trial of 23 overweight men given a high-fat breakfast challenge, an açai smoothie increased flow-mediated dilatation by 1.4% at 2 hours and 0.8% at 6 hours, versus 0.4% and -0.3% for control. The açai beverage also lowered postprandial total peroxide oxidative status. Blood pressure, heart rate, and glucose remained unchanged, whereas early insulin peaks and overall post-meal insulin exposure were higher following açai.
Alqurashi RM, Galante LA, Rowland IR, et al. Am J Clin Nutr, 2016. PMID 27680990
2016 / 8-week randomized, double-blind, placebo-controlled trial
Sixty-three overweight or obese Korean adults were randomized to receive either 2.5 g/d of anthocyanin-rich black soybean testa extract (BBT, n=32) or placebo (2.5 g/d starch, n=31) for 8 weeks. The BBT group experienced significant decreases in abdominal fat (waist circumference and hip circumference) as well as reductions in triacylglycerols, LDL cholesterol, and non-HDL cholesterol. Arteriosclerosis indicators (TC/HDLc and LDLc/HDLc) also significantly decreased in the BBT group but remained unchanged in the placebo group, with no differences observed between groups in energy-adjusted dietary intakes or physical activity.
Lee M, Sorn SR, Park Y, et al. J Med Food, 2016. PMID 27809637
2015 / Pooled analysis of randomized controlled trials
A pooled analysis evaluated two 6-month randomized trials involving 450 postmenopausal women with prehypertension or prediabetes. Compared with milk placebo, participants receiving combined soy foods had a smaller decline in serum uric acid, resulting in a net difference of 14.5 micromol/L (95% CI: 1.93-25.6, p = 0.023) or 4.9% (95% CI: 1.3-8.5%, p = 0.023). Soy foods did not raise absolute urate levels.
Liu ZM, Ho CS, Chen YM, et al. Eur J Nutr, 2015. PMID 24659208
2015 / Controlled trial
Thirty patients with type II diabetes 6 weeks post-bypass surgery received counseling on a Modified Portfolio Diet (MPD) including low fat, viscous fibers, soy protein, and almonds, while 7 patients with no diet therapy served as time controls. Consumption of the MPD led to a 19% relative reduction in LDL cholesterol (1.9 ± 0.8 vs 1.6 ± 0.6 mmol/L, p < 0.001) with no change in HDL cholesterol, and homocysteine levels dropped (10.1 ± 2.7 vs 7.9 ± 4 μmol/L, p = 0.006). Flow-mediated dilatation increased from 3.8 ± 3.8% to 6.5 ± 3.6% (p = 0.004) in treated patients while remaining constant in controls (p = 0.6), and endothelial progenitor cell numbers increased significantly (p < 0.02). Time controls showed no significant changes across these measures.
Keith M, Kuliszewski MA, Liao C, et al. Clin Nutr, 2015. PMID 25023926
2015 / Randomized controlled crossover trial
Thirty-one type 2 diabetes patients were randomized in a crossover trial to an 8-week legume-free Therapeutic Lifestyle Change (TLC) diet and an 8-week legume-based TLC diet (replacing two servings of red meat with legumes 3 days per week), separated by a 4-week washout. Compared with the control diet, the legume-based diet significantly decreased fasting blood glucose (P=0.04), fasting insulin (P=0.04), triglycerides (P=0.04), and LDL cholesterol (P=0.02). Total cholesterol decreased in both diets with no significant difference between them, and BMI, waist circumference, and systolic and diastolic blood pressure did not change significantly between diets.
Hosseinpour-Niazi S, Mirmiran P, Hedayati M, et al. Eur J Clin Nutr, 2015. PMID 25351652
2015 / Randomized controlled crossover trial
A randomized controlled crossover trial investigated the effects of 3-day antibacterial mouthwash use compared to control (water) in 15 treated hypertensive men and women. Mouthwash use led to decreased oral nitrate to nitrite reduction (P = 0.02), lower salivary nitrite (P = 0.01), higher salivary nitrate (P < 0.001), and a trend toward lower plasma nitrite (P = 0.09). In addition, mouthwash significantly increased systolic blood pressure relative to control (2.3 mm Hg; 95% CI: 0.5, 4.0; P = 0.01), with no significant effect on diastolic blood pressure (P = 0.4) or plasma cGMP (P = 0.7).
Bondonno CP, Liu AH, Croft KD, et al. Am J Hypertens, 2015. PMID 25359409
2015 / Parallel, single-blind randomized controlled trial
Seventy-five overweight adolescents were randomized to consume 28 g/day of brown flaxseed, golden flaxseed, or wheat bran (control) on weekdays for 11 weeks. Groups consuming brown and golden flaxseed demonstrated a significant reduction in diastolic blood pressure. Neither flaxseed variety differentially affected plasma lipids, glucose, or inflammatory profile, and all three groups showed increased TNF-α levels. The authors noted that adolescents consumed only about half the provided amount, which may have been insufficient to influence lipids, inflammation, or body composition.
Machado AM, de Paula H, Cardoso LD, et al. Nutrition, 2015. PMID 25441591
2015 / Randomized crossover controlled-feeding trial
In a randomized crossover controlled-feeding trial of 48 adults with high LDL cholesterol, consuming 1.5 oz daily of almonds for six weeks lowered non-HDL cholesterol by 6.9±2.4 mg/dL (P=0.01) and LDL cholesterol by 5.3±1.9 mg/dL (P=0.01) compared to an isocaloric muffin snack. Almond intake also decreased abdominal fat by 0.07±0.03 kg (P=0.02) and leg fat by 0.12±0.05 kg (P=0.02) without altering total weight. The control snack reduced HDL cholesterol, whereas almonds maintained baseline concentrations.
Berryman CE, West SG, Fleming JA, et al. J Am Heart Assoc, 2015. PMID 25559009
2015 / Randomized controlled trial
In an eight-week trial, 48 postmenopausal women with pre- and stage 1-hypertension received 22 g daily of freeze-dried blueberry powder or control powder. Systolic blood pressure (131±17 mm Hg, P<0.05), diastolic blood pressure (75±9 mm Hg, P<0.01), and brachial-ankle pulse wave velocity (1,401±122 cm/second, P<0.01) decreased significantly from baseline in the blueberry group, along with increased nitric oxide levels (15.35±11.16 μmol/L, P<0.01). No changes occurred in the control powder group.
Johnson SA, Figueroa A, Navaei N, et al. J Acad Nutr Diet, 2015. PMID 25578927
2015 / Randomized controlled trial
A randomized trial assigned 48 adults receiving ongoing statin therapy to add 100 grams of almonds daily or follow diet counseling alone for four weeks. Participants in the almond group showed a 4.9% reduction in non-HDL cholesterol compared with a 3.5% increase in the control group (p = 0.02). Non-significant reductions occurred for LDL cholesterol and triglycerides (p = 0.068 for both), while LDL particle distribution shifted from pattern A to B.
Ruisinger JF, Gibson CA, Backes JM, et al. J Clin Lipidol, 2015. PMID 25670361
2015 / Randomized crossover trial
A randomized crossover trial tested the effects of consuming high-nitrate vegetables versus avoiding them for one week in 19 healthy women. The high-nitrate diet raised plasma nitrate from 24.4 to 61.0 µmol/l and nitrite from 98 to 185 nmol/l (both P < 0.05). Resting systolic blood pressure was reduced from 107 to 103 mmHg after the high-nitrate diet (P < 0.05), whereas the control diet produced no significant changes.
Ashworth A, Mitchell K, Blackwell JR, et al. Public Health Nutr, 2015. PMID 25683748
2015 / Randomized controlled trial
In a randomized controlled trial, 240 adults with metabolic syndrome were assigned to a diet focused on increased fiber consumption versus the multicomponent American Heart Association (AHA) dietary guidelines. At 12 months, mean weight change was -2.1 kg (95% CI, -2.9 to -1.3 kg) in the high-fiber group versus -2.7 kg (CI, -3.5 to -2.0 kg) in the AHA group, with a mean between-group difference of 0.6 kg (CI, -0.5 to 1.7 kg). Eight participants developed diabetes (7 in high-fiber, 1 in AHA; P = 0.066), and dropout rates were 9.9% versus 12.6% (P = 0.55). Limitations noted include unknown generalizability, lack of weight maintenance assessment after sessions ended, and lack of power for dietary equivalence.
Ma Y, Olendzki BC, Wang J, et al. Ann Intern Med, 2015. PMID 25686165
2015 / Randomized controlled trial
A double-blind trial randomized 110 patients with peripheral artery disease to foods containing 30 g of milled flaxseed (n=58) or 30 g of whole wheat (n=52) daily for 12 months. Flaxseed lowered circulating LDL cholesterol by 15% at 1 month (P=0.05), though differences between groups were not significant at 12 months (P=0.33). In participants also taking cholesterol-lowering drugs, flaxseed decreased LDL cholesterol by 8.5% at 12 months compared to a 3.0% increase with placebo (P=0.030).
Edel AL, Rodriguez-Leyva D, Maddaford TG, et al. J Nutr, 2015. PMID 25694068
2015 / Randomized crossover trial
In a randomized crossover trial, 39 healthy normotensive adults consumed three test meals with varying sodium and potassium contents on separate occasions. Adding 38 mmol potassium to a 65 mmol sodium meal significantly attenuated the postmeal decrease in flow-mediated dilatation compared with a low-potassium, high-sodium meal (P < 0.05). No significant differences were observed between meals for pulse wave velocity, central augmentation index, or blood pressure.
Blanch N, Clifton PM, Petersen KS, et al. Am J Clin Nutr, 2015. PMID 25787997
2015 / Single-arm pre-post intervention study
Thirty young females with BMI >= 20 drank 280 mL of tomato juice daily (providing 32.5 mg of lycopene) for 2 months while maintaining their normal diet and exercise. Twenty-five participants completed the trial. Supplementation significantly decreased body weight, body fat, waist circumference, BMI, cholesterol, MCP-1, and thiobarbituric reactive substances, while increasing adiponectin, triglyceride, and lycopene levels. Decreases in waist circumference, cholesterol, and MCP-1 and increases in adiponectin and lycopene occurred regardless of whether participants experienced body fat reduction.
Li YF, Chang YY, Huang HC, et al. Nutrition, 2015. PMID 25837214
2015 / Randomized crossover trial
Nine healthy young men completed four 2-week interventions (normocaloric bedrest, normocaloric ambulatory, hypocaloric bedrest, hypocaloric ambulatory) separated by 5 months to examine the effects of a 25% caloric restriction and 6° head-down bedrest. Caloric restriction showed a strong trend toward reduced basal muscle sympathetic nerve activity (22±3 vs. 14±4 burst/min, p = 0.06). Both bedrest and caloric restriction were associated with lower systolic blood pressure during lower body negative pressure (p < 0.01), but heart rate increased with bedrest and decreased with caloric restriction. Survival analysis demonstrated a significant reduction in orthostatic tolerance following caloric restriction (normocaloric finishers: 12/16; hypocaloric finishers: 6/16; p = 0.03).
Florian JP, Baisch FJ, Heer M, et al. PLoS One, 2015. PMID 25915488
2015 / Randomized crossover trial
In a randomized crossover trial, 22 acute coronary syndrome patients consumed cereal products made from organic semi-whole khorasan wheat or modern control wheat for eight weeks each. The khorasan intervention significantly lowered total cholesterol by 6.8%, LDL cholesterol by 8.1%, glucose by 8%, and insulin by 24.6% from baseline. It also reduced reactive oxygen species, tumor necrosis factor-alpha, and lipoperoxidation of circulating monocytes and lymphocytes, whereas control wheat produced no significant changes.
Whittaker A, Sofi F, Luisi ML, et al. Nutrients, 2015. PMID 25970146
2015 / Randomized crossover controlled feeding study
Ten salt-resistant and ten salt-sensitive healthy, normotensive participants completed a controlled feeding study with a run-in diet followed by a 7-day low-sodium diet (20 mmol/day) and a 7-day high-sodium diet (300 mmol/day) in random order. Brachial artery flow-mediated dilation (FMD) was lower during the high-sodium diet compared to the low-sodium diet in both groups (P < 0.001) without differing between groups (FMD: SR LS 10.6 ± 1.3%, SR HS 7.2 ± 1.5%, SS LS 12.5 ± 1.7%, SS HS 7.8 ± 1.4%). Thus, high dietary sodium impaired brachial artery FMD to a similar extent regardless of salt sensitivity.
Matthews EL, Brian MS, Ramick MG, et al. J Appl Physiol (1985), 2015. PMID 26078434
2015 / Randomized crossover trial
A randomized crossover trial evaluated adding 85 grams of almonds daily to an NCEP Step 1 diet for 6 weeks in 45 patients with coronary artery disease. Almond supplementation raised plasma α-tocopherol by 5.8% (P ≤ 0.05) and improved intakes of fiber, calcium, magnesium, and choline. However, it did not significantly alter vascular function, blood pressure, lipids, or inflammatory markers such as C-reactive protein or tumor necrosis factor-α.
Chen CY, Holbrook M, Duess MA, et al. Nutr J, 2015. PMID 26080804
2015 / Experimental animal study and pilot clinical trial
Cycles of a fasting mimicking diet extended lifespan, stimulated stem cell regeneration upon re-feeding, reduced visceral fat, decreased cancer incidence, and improved cognitive performance in mice. In a pilot clinical trial, three cycles of the fasting mimicking diet decreased risk factors and biomarkers associated with aging, diabetes, cardiovascular disease, and cancer without causing major adverse effects.
Brandhorst S, Choi IY, Wei M, et al. Cell Metab, 2015. PMID 26094889
2015 / Randomized crossover trial
Fourteen overweight postmenopausal women consumed three 2-week isocaloric diets containing high-fat cheese, high-fat meat, or high carbohydrates in a randomized crossover design. Compared to the carbohydrate diet, the cheese diet increased HDL cholesterol by 5% (P = 0.012) and the meat diet increased it by 8% (P < 0.001). Total cholesterol, LDL cholesterol, and triglycerides did not differ, whereas both cheese and meat diets increased fecal fat and bile acid excretion.
NANO counterpoint →
Thorning TK, Raziani F, Bendsen NT, et al. Am J Clin Nutr, 2015. PMID 26178720
2015 / Randomized controlled trial
In a 2-year trial, 218 nonobese adults aged 21-51 years were randomized to 25% caloric restriction or ad libitum diet. The restriction group achieved 11.7% calorie reduction and sustained 10.4% weight loss. Triiodothyronine decreased significantly more in the restricted group at 12 and 24 months (P<0.001), while weight-adjusted resting metabolic rate fell significantly more at 12 months (P=0.04) but not at 24 months. Core temperature was unchanged, and cardiometabolic risk factors decreased without harming quality of life.
Ravussin E, Redman LM, Rochon J, et al. J Gerontol A Biol Sci Med Sci, 2015. PMID 26187233